Medidata and Techfields Launch mHealth Stroke Study
MediData announced that Techfields Pharma has selected its Clinical Cloud solution to power a Phase II schemic stroke study.
Medidata announced that Techfields Pharma has selected its Clinical Cloud solution to power a Phase II schemic stroke study. The China-based company plans to use Medidata’s solution and mHealth technology to improve trial processes and gather new insights.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025